• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DURATIONS 随机试验设计:估计目标、分析方法和运行特征。

The DURATIONS randomised trial design: Estimation targets, analysis methods and operating characteristics.

机构信息

MRC Clinical Trials Unit, University College London Institute for Clinical Trials and Methodology, London, UK.

出版信息

Clin Trials. 2020 Dec;17(6):644-653. doi: 10.1177/1740774520944377. Epub 2020 Aug 16.

DOI:10.1177/1740774520944377
PMID:33153304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7851720/
Abstract

BACKGROUND

Designing trials to reduce treatment duration is important in several therapeutic areas, including tuberculosis and bacterial infections. We recently proposed a new randomised trial design to overcome some of the limitations of standard two-arm non-inferiority trials. This DURATIONS design involves randomising patients to a number of duration arms and modelling the so-called 'duration-response curve'. This article investigates the operating characteristics (type-1 and type-2 errors) of different statistical methods of drawing inference from the estimated curve.

METHODS

Our first estimation target is the shortest duration non-inferior to the control (maximum) duration within a specific risk difference margin. We compare different methods of estimating this quantity, including using model confidence bands, the delta method and bootstrap. We then explore the generalisability of results to estimation targets which focus on absolute event rates, risk ratio and gradient of the curve.

RESULTS

We show through simulations that, in most scenarios and for most of the estimation targets, using the bootstrap to estimate variability around the target duration leads to good results for DURATIONS design-appropriate quantities analogous to power and type-1 error. Using model confidence bands is not recommended, while the delta method leads to inflated type-1 error in some scenarios, particularly when the optimal duration is very close to one of the randomised durations.

CONCLUSIONS

Using the bootstrap to estimate the optimal duration in a DURATIONS design has good operating characteristics in a wide range of scenarios and can be used with confidence by researchers wishing to design a DURATIONS trial to reduce treatment duration. Uncertainty around several different targets can be estimated with this bootstrap approach.

摘要

背景

在包括结核病和细菌感染在内的多个治疗领域,缩短治疗时间的临床试验设计非常重要。我们最近提出了一种新的随机临床试验设计,以克服标准两臂非劣效试验的一些局限性。这种 DURATIONS 设计涉及将患者随机分配到多个时间臂,并对所谓的“时间-反应曲线”进行建模。本文研究了从估计曲线得出推断的不同统计方法的操作特性(Ⅰ型和Ⅱ型错误)。

方法

我们的第一个估计目标是在特定风险差异范围内,比对照(最大)时间短的最短非劣效时间。我们比较了不同的估计方法,包括使用模型置信区间、Delta 方法和 bootstrap。然后,我们探索了结果对关注绝对事件率、风险比和曲线斜率的估计目标的泛化能力。

结果

通过模拟表明,在大多数情况下,对于大多数估计目标,使用 bootstrap 估计目标时间的变异性可得到适合 DURATIONS 设计的良好结果,类似于功效和Ⅰ型错误的数量。不建议使用模型置信区间,而在某些情况下,Delta 方法会导致Ⅰ型错误膨胀,特别是当最佳时间非常接近随机时间之一时。

结论

在 DURATIONS 设计中使用 bootstrap 估计最佳时间在广泛的场景中具有良好的操作特性,希望设计缩短治疗时间的 DURATIONS 试验的研究人员可以有信心地使用。这种 bootstrap 方法可以估计几个不同目标的不确定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/2da88680fe57/10.1177_1740774520944377-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/8b7776fa03bc/10.1177_1740774520944377-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/f5e226780161/10.1177_1740774520944377-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/bb995924a8d4/10.1177_1740774520944377-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/2da88680fe57/10.1177_1740774520944377-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/8b7776fa03bc/10.1177_1740774520944377-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/f5e226780161/10.1177_1740774520944377-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/bb995924a8d4/10.1177_1740774520944377-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102e/7851720/2da88680fe57/10.1177_1740774520944377-fig4.jpg

相似文献

1
The DURATIONS randomised trial design: Estimation targets, analysis methods and operating characteristics.DURATIONS 随机试验设计:估计目标、分析方法和运行特征。
Clin Trials. 2020 Dec;17(6):644-653. doi: 10.1177/1740774520944377. Epub 2020 Aug 16.
2
Rethinking non-inferiority: a practical trial design for optimising treatment duration.重新思考非劣效性:优化治疗持续时间的实用试验设计。
Clin Trials. 2018 Oct;15(5):477-488. doi: 10.1177/1740774518778027. Epub 2018 Jun 5.
3
Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.适用于具有连续结局的部分嵌套随机对照试验的适当统计方法:一项模拟研究。
BMC Med Res Methodol. 2018 Oct 11;18(1):105. doi: 10.1186/s12874-018-0559-x.
4
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.处理非劣效试验中不确定的对照组事件风险:非劣效前沿和稳定功效转换。
Trials. 2020 Feb 6;21(1):145. doi: 10.1186/s13063-020-4070-4.
5
A simulation study for comparing testing statistics in response-adaptive randomization.一种用于比较响应自适应随机化中检验统计量的仿真研究。
BMC Med Res Methodol. 2010 Jun 5;10:48. doi: 10.1186/1471-2288-10-48.
6
Noninferiority trials with nonadherence to the assigned randomized treatment.存在不依从指定随机治疗情况的非劣效性试验。
Clin Trials. 2019 Dec;16(6):673-681. doi: 10.1177/1740774519868479. Epub 2019 Aug 14.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.基于ROC曲线下配对面积的诊断准确性等效性和非劣效性检验。
Stat Med. 2006 Apr 15;25(7):1219-38. doi: 10.1002/sim.2358.
9
When inferiority meets non-inferiority: implications for interim analyses.当劣势遭遇非劣效性:对期中分析的影响。
Clin Trials. 2012 Oct;9(5):605-9. doi: 10.1177/1740774512453220. Epub 2012 Jul 13.
10
Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics.多臂多阶段(MAMS)随机选择设计:治疗选择规则对操作特性的影响。
BMC Med Res Methodol. 2024 Jun 3;24(1):124. doi: 10.1186/s12874-024-02247-w.

引用本文的文献

1
The effect of pericapsular nerve group (PENG) block on postoperative analgesia in elderly patients who underwent proximal femoral nail anti-rotation surgery: a prospective, randomized-controlled trial.囊周神经群(PENG)阻滞对老年股骨近端防旋髓内钉(PFNA)手术后患者术后镇痛效果的影响:一项前瞻性、随机对照试验。
BMC Anesthesiol. 2024 Nov 21;24(1):421. doi: 10.1186/s12871-024-02805-1.
2
The optimal antibiotic treatment duration for community-acquired pneumonia in adults diagnosed in general practice in Denmark (CAP-D): an open-label, pragmatic, randomised controlled trial.丹麦普通实践中诊断的成人社区获得性肺炎(CAP-D)的最佳抗生素治疗持续时间:一项开放标签、实用、随机对照试验。
Trials. 2024 Sep 27;25(1):627. doi: 10.1186/s13063-024-08477-z.
3

本文引用的文献

1
Optimising trial designs to identify appropriate antibiotic treatment durations.优化试验设计以确定合适的抗生素治疗持续时间。
BMC Med. 2019 Jun 21;17(1):115. doi: 10.1186/s12916-019-1348-z.
2
Potential for Erosion of Efficacy in Noninferiority Trials of Decreasing Duration of Antibiotic Therapy.抗生素治疗疗程缩短的非劣效性试验中疗效降低的可能性。
Clin Infect Dis. 2019 Sep 13;69(7):1262. doi: 10.1093/cid/ciz103.
3
Using simulation studies to evaluate statistical methods.运用模拟研究评估统计方法。
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047).根治性前列腺切除术术后无、短期或长期雄激素剥夺治疗联合放疗的随机临床试验:RADICALS-HD(NCT00541047)三方比较结果
Eur Urol. 2024 Nov;86(5):422-430. doi: 10.1016/j.eururo.2024.07.026. Epub 2024 Aug 31.
4
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system.延长间隔给药的预期环境和公共卫生效益:在美国国家卫生系统中使用帕博利珠单抗的分析。
Lancet Oncol. 2024 Jun;25(6):802-810. doi: 10.1016/S1470-2045(24)00200-6.
5
Analgesic efficacy of an opioid-free postoperative pain management strategy versus a conventional opioid-based strategy following laparoscopic radical gastrectomy: an open-label, randomized, controlled, non-inferiority trial.腹腔镜根治性胃切除术后无阿片类药物的术后疼痛管理策略与传统阿片类药物为基础的策略的镇痛效果:一项开放标签、随机、对照、非劣效性试验。
World J Surg Oncol. 2024 Feb 15;22(1):54. doi: 10.1186/s12957-023-03298-x.
6
Targeted randomization dose optimization trials enable fractional dosing of scarce drugs.靶向随机化剂量优化试验可实现稀缺药物的分数剂量给药。
PLoS One. 2023 Oct 30;18(10):e0287511. doi: 10.1371/journal.pone.0287511. eCollection 2023.
7
Analgesic efficacy of an opioid-free postoperative pain management strategy versus a conventional opioid-based strategy following open major hepatectomy: an open-label, randomised, controlled, non-inferiority trial.开放性大肝切除术后无阿片类药物的术后疼痛管理策略与传统阿片类药物为主的策略的镇痛效果:一项开放标签、随机、对照、非劣效性试验。
EClinicalMedicine. 2023 Aug 31;63:102188. doi: 10.1016/j.eclinm.2023.102188. eCollection 2023 Sep.
8
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.REFINE-Lung 采用了一种新颖的多臂随机试验设计,以解决可能的免疫治疗过度治疗问题。
Lancet Oncol. 2023 May;24(5):e219-e227. doi: 10.1016/S1470-2045(23)00095-5.
9
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers.REFINE(癌症中降低频率的免疫检查点抑制):一项多臂二期篮子试验,在不同癌症中测试降低强度的免疫治疗。
Contemp Clin Trials. 2023 Jan;124:107030. doi: 10.1016/j.cct.2022.107030. Epub 2022 Nov 26.
10
Dose optimisation and scarce resource allocation: two sides of the same coin.剂量优化和稀缺资源分配:同一枚硬币的两面。
BMJ Open. 2022 Oct 12;12(10):e063436. doi: 10.1136/bmjopen-2022-063436.
Stat Med. 2019 May 20;38(11):2074-2102. doi: 10.1002/sim.8086. Epub 2019 Jan 16.
4
Rethinking non-inferiority: a practical trial design for optimising treatment duration.重新思考非劣效性:优化治疗持续时间的实用试验设计。
Clin Trials. 2018 Oct;15(5):477-488. doi: 10.1177/1740774518778027. Epub 2018 Jun 5.
5
The antibiotic course has had its day.抗生素疗程已经过时了。
BMJ. 2017 Jul 26;358:j3418. doi: 10.1136/bmj.j3418.
6
Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.非劣效性试验:它们是否较差?对主要医学期刊报告的系统评价。
BMJ Open. 2016 Oct 7;6(10):e012594. doi: 10.1136/bmjopen-2016-012594.
7
Development of gatekeeping strategies in confirmatory clinical trials.确证性临床试验中把关策略的制定。
Biom J. 2011 Nov;53(6):875-93. doi: 10.1002/bimj.201100036.
8
A graphical approach to sequentially rejective multiple test procedures.一种用于序贯拒绝多重检验程序的图形方法。
Stat Med. 2009 Feb 15;28(4):586-604. doi: 10.1002/sim.3495.
9
Issues in noninferiority trials: the evidence in community-acquired pneumonia.非劣效性试验中的问题:社区获得性肺炎的证据
Clin Infect Dis. 2008 Dec 1;47 Suppl 3(Suppl 3):S108-20. doi: 10.1086/591390.
10
Model averaging using fractional polynomials to estimate a safe level of exposure.使用分数多项式进行模型平均以估计安全暴露水平。
Risk Anal. 2007 Feb;27(1):111-23. doi: 10.1111/j.1539-6924.2006.00863.x.